MBX Capital
14 portfolio companies · 4 on the map · $494.7M raised · 3 cities
Portfolio map
4 MBX Capital portfolio companies on the map.
Portfolio companies

Tidal Vision
Bellingham
Tidal Vision manufactures chitosan-based biomolecular solutions for some of humanity's chemistry and pollution.
Biotechnology Research$366.2MEst. 2015
Arine
San Francisco
Arine is the leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and risk-based provider organizations to enhance medication safety, adherence, and effectiveness among their members.
Hospitals and Health Care$70M
Concert Health
San Diego
America’s leading behavioral health medical group with a turnkey solution for primary care
Mental Health Care$58.5MEst. 2016
Vivodyne
San Francisco
Vivodyne is a company dedicated to accelerating the discovery of cures for human diseases. Its mission frames the company's purpose.
BiotechnologySeries AEst. 2020
More portfolio companies
10 more MBX Capital investments we track beyond the map.
CareRevLos Angeles · Series A
Attivare TherapeuticsNatick · Seed
Catena BiosciencesBerkeley · Seed
Macro TrialsLos Angeles · Seed
CND Life SciencesScottsdale · Series A
ContralineCharlottesville · Series A
LunaNashville · Series B
Juniper GenomicsToronto · Seed
ForumNew York · Seed
OFFOR HealthColumbus · Series A
Portfolio map
4 MBX Capital portfolio companies on the map.